Drug Approval Signals New Options for Stroke, Heart Attack Survivors in Europe
Heart patients in Europe have something to celebrate. This week, the European Commission approved a groundbreaking new drug, evolocumab, to prevent heart attack and stroke for patients who have already survived a cardiac event.
